Company registration number 12369627 (England and Wales)
NEVRARGENICS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023
PAGES FOR FILING WITH REGISTRAR
NEVRARGENICS LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2023
31 December 2023
- 1 -
2023
2022
£
£
£
£
Fixed assets
2,661
4,657
Current assets
9,289
228,280
Prepayments and accrued income
399
309
Creditors: amounts falling due within one year
(58,145)
3,345
Net current (liabilities)/assets
(48,457)
231,934
Total assets less current liabilities
(45,796)
236,591
Net (liabilities)/assets
(45,796)
236,591
Capital and reserves
(45,796)
236,591
Notes to the financial statements
1
Employees
The average number of persons, including directors, employed by the company during the year was as follows:
2023
2022
Number
Number
Employees
5
4
Nevrargenics Limited is a private company limited by shares incorporated in England and Wales. The registered office is Unit 31A Ouse House, Mandale Park, Belmont Industrial Estate, Durham, DH1 1TT.
For the year ended 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
NEVRARGENICS LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 DECEMBER 2023
31 December 2023
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 6 March 2024 and are signed on its behalf by:
Prof A Whiting
Director
Company registration number 12369627 (England and Wales)